UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                  FORM 10-KSB/A


(MARK ONE)

/X/  ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE  SECURITIES  EXCHANGE ACT OF
     1934

For the fiscal year ended October 31, 2004

/_/  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT
     OF 1934 For the transition period from ____________ to ____________

Commission file number: 0-33229


                        Bio Solutions Manufacturing, Inc.
--------------------------------------------------------------------------------
                 (NAME OF SMALL BUSINESS ISSUER IN ITS CHARTER)

        New York                                              16-1576984
--------------------------------------------------------------------------------
(STATE OR OTHER JURISDICTION OF                        (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION)                                IDENTIFICATION NO.

1161 James Street, Hattiesburg, Mississippi                  39401-4016
--------------------------------------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)                     (ZIP CODE)

Issuer's telephone number: (601) 582-4000

Securities registered under Section 12(b) of the Exchange Act:

Title of each class                    Name of each exchange on which registered
-------------------                    -----------------------------------------
         None                                             None

Securities registered under Section 12(g) of the Exchange Act:

                         Common Stock, $.0001 par value
--------------------------------------------------------------------------------
                                (TITLE OF CLASS)




<PAGE>


     Check  whether  the issuer (1) filed all  reports  required  to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the issuer was required to file such  reports),  and (2) has
been subject to such filing requirements for the past 90 days. Yes /X/ No /_/


     Check if there is no disclosure  of  delinquent  filers in response to Item
405 of  Regulation  S-B  contained  in  this  form,  and no  disclosure  will be
contained, to the best of issuer's knowledge, in definitive proxy or information
statements  incorporated  by  reference  in Part III of this Form  10-KSB or any
amendment to this Form 10-KSB. /X/



     Issuer's revenues for its most recent fiscal year (ended October 31, 2004):
$191,732.



     The aggregate market value of the voting and non-voting  common equity held
by non-  affiliates  of the  issuer,  based upon the price at which such  common
equity was sold on February 9, 2005, as reported by the OTC Bulletin Board,  was
approximately  $12,339,228.  Shares of common  stock  held by each  officer  and
director and by each person who owns 5% or more of the outstanding  common stock
have been  excluded in that such  persons may be deemed to be  affiliates.  This
determination of affiliate status is not necessarily a conclusive  determination
for other purposes.

     The number of outstanding  shares of the issuer's  common stock on February
9, 2005 was 16,409,228.


Documents incorporated by reference: None.


Transitional Small Business Disclosure Format (CHECK ONE): Yes /_/ No /X/



<PAGE>



                                     PART I

ITEM 1.  DESCRIPTION OF BUSINESS.

     CORPORATE HISTORY. Bio Solutions  Manufacturing,  Inc. (the "Company") is a
New York  corporation that was formed on September 19, 1994. Prior to the fourth
quarter of 2000, the Company operated under the name "Ream Printing Paper Corp."
and had not  engaged  in any  business  for a number of years.  From the  fourth
quarter of 2000 until March,  2004,  the Company  operated under the name Single
Source  Financial  Services  Corporation  ("SSFS") and engaged in the electronic
transaction processing business.

     In March,  2004,  the Company  acquired  all of the issued and  outstanding
stock of Bio Solutions  Manufacturing,  Inc., a Nevada corporation,  in exchange
for  approximately  92% of its issued and outstanding  common stock. The Company
changed its name to Bio Solutions  Manufacturing,  Inc.  ("BSM") and the name of
its wholly  owned  subsidiary  was changed to Bio  Solutions,  Production,  Inc.
("BSP").  Through BSP,  the Company is engaged in the business of  manufacturing
environmentally safe bio-remediation products for the treatment of various forms
of waste by the food service  industry and municipal waste treatment  plants and
other customers throughout the United States.

     CURRENT  BUSINESS.  On  January  27,  2004,  the  Company  entered  into  a
Reorganization  and Stock Purchase Agreement and certain related agreements with
Bio-Solutions  Manufacturing,  Inc. ("BSM") pursuant to which the Company agreed
to  issue  11,865,000  shares  of  its  common  stock  (which  would  constitute
approximately  92% of the Company's  outstanding  shares) to the shareholders of
BSM in return for all of the outstanding shares of BSM (the "BSM  Transaction").
BSM was a privately-held company that provides environmentally-safe solutions to
restaurants, municipal waste treatment plants and other customers throughout the
United  States  which  are  seeking   environmentally-friendly  forms  of  waste
remediation..  In connection with the BSM  Transaction,  the parties agreed that
certain  other  actions  would be taken  either  prior to or after the  closing,
including  (i) the  transfer  to Single  Source  Electronic  Transactions,  Inc.
("SSET"),  a wholly owned  subsidiary of SSFS, of all of the Company's shares in
SSFS Merchant Services,  Inc.(" SSFSM") and CardReady of New York, Inc.("CRNY"),
so that those entities became wholly- owned  subsidiaries of SSET, (ii) the sale
of all of the shares of SSET owned by BSM to the former control  shareholders of
SSFS for the payment of nominal  consideration (iii) the Company's  cancellation
of its  previous  exercise  of the  CardReady  Option  and the  transfer  of the
CardReady Option to SSET.  Subject to the satisfaction of the conditions  stated
in the parties' agreements, the transaction was completed in March, 2004.

Business Development

     BSM is a technology  provider of biological  solutions to  industries  that
desire   environmentally-friendly   forms  of  waste  remediation.  The  Company
(formerly known as Single Source Financial Services Corporation),  is the parent
of Bio  Solutions  Production,  Inc.  ("BSP")(formerly  known  as Bio  Solutions



<PAGE>



Manufacturing,  Inc.), a Nevada corporation, that was acquired in March, 2004 in
exchange  for  92% of the  Company's  issued  and  outstanding  stock.  BSP is a
biotechnology company,  which owns intellectual  properties for the construction
and process of  microbial  products  with  remedies  for  certain  environmental
applications and production of value- added products. The Company's products are
sold through Bio Solutions Franchise Corp. ("BSFC"),  an unrelated company. BSFC
is a sales and marketing company for environmental  application products that is
currently  building  a  network  of  franchises  to  sell  and  service  certain
applications while recruiting and training qualified  distributors and strategic
partners for the more  complicated  markets.  BSFC owns the exclusive  marketing
rights for all of BSP's environmental related products.

     The   Company's   principal   place  of  business  is  1161  James  Street,
Hattiesburg,  MS  39401  and its  telephone  number  at that  address  is  (601)
582-4000.

     The Company is  presently  trading on the Over the Counter  Bulletin  Board
("OTCBB") under the symbol BSLM.

     See (b) "Business of Registrant" immediately below for a description of the
Company's business. Business of Registrant

GENERAL

     Clogged  drains  can be a nasty  and  expensive  problem  in a  residential
setting.  However,  the  problem  is usually  limited in its scope and  remedied
without  reoccurrence.  Conversely,  in  restaurants,  groceries,  hospitals and
schools clogged drains are a never ending battle, which require a budget with no
ceiling and downtime which can never be afforded. Many facilities use mechanical
devices which merely bore a small hole which is still  susceptible  to plugging.
Liquid  products such as acids,  caustics and solvents only open a small portion
of the pipe temporarily.

     As waste treatment becomes a more prominent  industry,  many  organizations
are exploring the  possibilities  of biological  waste  treatment.  From clogged
grease traps to industrial waste and sewage,  companies are seeking the aid of a
more natural treatment method.

     Bacteria  and enzymes  have  provided a method to  accelerate  nature's own
bioremediation  process.  In the  environment,  both bacteria and enzymes play a
part  in   biodegradation.   Bacteria   produce   the  enzymes   essential   for
biometabolism.  The enzymes then do their part to ease the metabolic  reactions.
The live  microbes in these  treatments  actually eat the grease or other waste.
These microbes continue to devour the grease or other waste as long as treatment
is continued. These solutions are: cost-effective; environmentally friendly; low
maintenance;  and  dependable.  The solutions  can:  eliminate  grease and fats;
reduce  Hydrogen  Sulfide  and  ammonia  levels;   reseed  bio-  filters/plants;
breakdown hydrocarbons;  control odors; and improve sludge management.  Areas in
which the  solutions  have proved  successful  include:  waste  water  treatment
plants;  sewer lines and lift stations;  lagoons,  holding tanks and aquaculture
ponds; drain lines and grease traps; septic tanks, cesspools and drain fields.

     The Company  believes  that its products and  technology  are more advanced
than similar products on the market.  BSFC has developed a franchise  program to
expand the end users to whom BSM's products are ultimately sold.




<PAGE>



PRINCIPAL PRODUCTS AND SERVICES

     The  Company's   products  have  a  combination  of  microbes  and  enzymes
specifically  selected,  adapted and mixed in laboratories.  These microbes have
been designed to digest animal and plant tissues,  proteins and  cellulose.  The
formulation  of the  products has been  developed  to digest the waste  products
effectively and in an environmentally safe and responsible manner. This is based
on several years of research and development work.

     As soon as the microbes are activated by contact with any moisture, they go
to work,  break down targeted  complex  substances and convert them into simple,
harmless and elemental substances. When the complex substances and compounds are
digested and broken down into simpler  elements,  the noxious  odors  associated
with (for  example)  sulfides,  ammonia,  nitrates  and  others  are  reduced or
eliminated and simpler  elemental  substances  flow out in the effluents.  These
effluents will have  acceptable  levels of BOD (Biological  Oxygen Demand),  TSS
(Total Suspended  Solids),  FOG (Fats, Oil and Grease),  etc., which thus become
harmless.

The Company's primary products are the following:

Product                             Purpose
--------------------------------------------------------------------------------

BP - 310                            Treatment  of  Grease  Traps/Lift  Stations,
                                    primarily enzymatic reactions
BP - 710                            Treatment of Grease Traps/Lift Stations,
                                    primarily microbial actions
BP - 910                            Treatment of Portable Toilets
BP - 101                            Specific for Higher Carbohydrate Complex
BO - 102                            Specific for Higher Fats and Oils
Buffer                              Balancing pH
Bio - Care H2S                      Specific for Hydrogen Sulfide Reduction
Bio - Care G                        Liquefies Hard Grease/Fat
Bio - Care Wheels                   Cleans  Grease  and  Dirt  off the  Wheels
                                    of Trolleys in Restaurants
Bio - Care H & S (Hood & Stack)     Degreases Hoods and Stacks in Restaurants
Bio - Catalyst                      Enhances Activity of BP - 310 and BP - 710
Bio - Care Lift Station             For Odor Control
Bio - Deplugger (for Drain Lines)   For Blocked Drain Lines
Bio - Care F (Floor Soap)           Cleans Grease and Dirt off Hard Surfaces
ECT - 2000                          Waste Water Disinfectant
Bio - Care Carpet Cleaner          Cleans carpets of all types by removing dirt,
                                   grease and stains
Bio - Care Oil and Grease          Cleans oil, grease, and dirt build-up on hard
                                   surfaces of Spot Cleaner parking lots, garage
                                   floors, sidewalks, etc.
Bio - Care Glass Cleaner           Cleans oil, grease, dirt and many other spots
                                   on all glass surfaces

DEPENDENCE ON NEW PRODUCTS

     The  Company  believes  its  ability  to grow in its  existing  markets  is
partially  dependent upon its ability to introduce new and  innovative  products
into such markets.  Although the Company seeks to introduce  additional products
each year in its existing  markets,  the success of new products is subject to a
number  of  conditions,  including  developing  products  that  will  appeal  to
customers  and comply with  existing  regulations  at the time of  introduction.
There can be no assurance that the Company's  efforts to develop  innovative new
products will be successful,  that  customers will accept new products,  or that


<PAGE>



the Company will obtain regulatory approvals of such new products,  if required.
In addition, no assurance can be given that new products currently  experiencing
strong popularity and rapid growth will maintain their sales over time.

     The  products and services  still in the  research  and  development  phase
include the following:

Products under R & D                        Purpose
--------------------------------------------------------------------------------
Acquaculture
Products for Cat Fish:              To produce disease free and better quality
                                    cat fish more economically.
Acquaculture Products for Shrimp:   To produce disease free & better quality
                                    shrimp more economically.
Bio - Peel Gum                      Peels off chewing gum from the surface of
                                    concrete & similar areas.
Bio - Care Algae                    To control algae in Ponds, Lakes, Golf
                                    Courses, etc.
Bio - Care Hydrocarbons             To treat contamination associated with
                                    petroleum & oil spills.

MANUFACTURING

     The Company is manufacturing  several biological  products  incorporating a
combination  of microbes  and enzymes.  These  microbes  have been  specifically
selected,  adapted,  dried and mixed in the Company's  laboratories,  located at
1161 James  Street.  The  combinations  have been  designed to digest animal and
plant tissues,  proteins and cellulose.  The  formulations  of the products have
been   developed   to  digest  the  waste   products   effectively   and  in  an
environmentally  safe and responsible  manner. This is based on several years of
research and development work.

     The  Company's  products  break down complex  waste  products  into simple,
harmless and elemental  substances.  Depending upon the nature and concentration
of the  pollutants  and  other  variables  encountered,  such  as pH,  time  and
temperature,  appropriate  additives are introduced to successfully complete the
bio-augmentation process. When the complex substances and compounds are digested
and broken down into simpler  elements,  the noxious odors  associated with, for
example  sulfides,  ammonia,  nitrites and others are  significantly  reduced or
eliminated  and  simpler  elemental   substances  flow  out  in  the  effluents.
Furthermore,  the end product obtained by using the Company's  products on dairy
and hog lagoons proved to be a valuable soil fertilizer.


MARKETING, SALES AND DISTRIBUTION

MARKET

     According to the research firm Environmental  Business  International,  the
overall environmental services industry grew at an annual rate of 2.7 percent in
1997 to  produce a total  output of $186  billion.  Approximately  117,000  U.S.
companies  are engaged in the  business  of  environmental  technologies  of all
kinds.

     According to the research  firm  Business  Communications  Co.,  Inc.,  the
market for wastewater  bioremediation was $353 million in 1998 and was projected
to grow to $374 million in 2001, an AAGR of 2.9%. The market for municipal solid
waste  management  had a 1998 value of $237 million and was expected to be worth
$262 million in 2001, an AAGR of 5.1%. The conversion of  waste-to-energy  was a
$66 million  sector of the  bioremediation  market in 1998 and was  projected to
account for $67 million in 2001, an AAGR of 0.8%.



<PAGE>



     BSFC plans to expand the sale of BSM's  products  using  franchising as its
distribution  approach.  BSFC's market position is best examined by reference to
some of its direct  franchising  competitors.  The following two (2) competitors
claim they will have between thirty percent (30%) and one hundred percent (100%)
growth in the number of franchises over the next year.

     Direct franchise competitor,  BioLogix(R) Systems Corporation, based in St.
Louis, Missouri,  claims to be a leader in the rapidly growing biotechnology and
environmental service industry,  widely known as "first" in innovation for waste
(grease) elimination. Founded in 1989, this competitor currently had thirty-five
(35)  employees  and revenue was $5 million in 1999 fiscal year and had nineteen
(19) franchisees in twelve (12) states.  BioLogix  projects growth of twenty-two
(22) more franchises in the next twelve (12) months.

     Direct  franchise  competitor,   Environmental   Biotech,  Inc.,  based  in
Sarasota,  Florida,  had $2.4  million of revenue in 1999.  They claim to be the
world leader in waste  bioremediation  technology.  They started  franchising in
1991  and have  over  sixty-six  (66)  franchises  in the USA as well as  master
franchises and service sub-franchisees in Australia,  Canada,  Colombia,  Japan,
Malaysia, Mexico, Singapore, Slovenia and the United Arab Emirates.

UNITED STATES MARKET FOR ENVIRONMENTAL SERVICES

     The Company operates in the environmental technology and services industry.
According to the U.S.  Industry and Trade  Outlook 2000  published by the United
States  Department  of Commerce,  the  environmental  technologies  and services
industry includes air, water and soil pollution  control;  solid and toxic waste
management;  site  remediation;  engineering,  design and  consulting  services;
environmental   monitoring;   recycling;   and   industrial  and  clean  process
technology.

     This mature  industry has evolved in response to growing  concern about the
risks and costs of pollution and the enactment of pollution control  legislation
in  the  United  States  and  around  the  world.  The  highly  fragmented  U.S.
environmental  industry is large and complex,  consisting of both investor-owned
and government  entities that provide  everything  from  small-scale  consulting
services to large-scale water utility operations.



<PAGE>



     According to  Environmental  Business  International  of San Diego, CA, the
industry  grew at an annual  rate of 2.7% in 1997 to  produce a total  output of
$186 billion, up from $181 billion in 1996. The environmental sector's customers
range from individual  consumers,  to locally regulated water utility monopolies
and  partnerships,  to  major  U.S.  corporations.  Approximately  117,000  U.S.
companies are engaged in the business of environmental technologies,  with 4,300
of those firms  exporting  internationally,  generating  $18.2 billion in export
revenues and creating a trade surplus of $9.1 billion in 1997.

     The  research  firm of  Environmental  Business  International  breaks  the
industry  down even further into  fourteen  (14)  segments of business  activity
which are  divided  into three (3) broad  categories:  services,  equipment  and
resources. These environmental industry segments are classifications of types of
businesses set out by the U.S. Standard Industry  Classifications  (SIC) system.
Service  revenues  are  those  generated  as fees  paid for  service,  equipment
revenues are sales of hardware and resources  are sales of  materials,  water or
energy.  The Company primarily serves the "Remediation and Industrial  Services"
segment.  This remediation segment in which the Company operates is estimated to
generate approximately $12 billion a year in revenue.

THE BIOREMEDIATION MARKET SUB-SECTOR

     According to the research firm Business  Communications  Co.,  Inc.("BCC"),
municipal  water  treatment  has  relied on the use of  microorganisms  for many
decades. Without biological contractors,  trickling filters, or various kinds of
digesters,   it  would  be  prohibitively  expensive  to  purify  municipal  and
commercial  wastewater.  Nearly sixty-five  percent (65%) of the municipal waste
generated  in the U.S.  each  year  (mainly  paper,  yard and food  wastes)  are
considered easily biodegradable and therefore amenable to biological  treatment.
Another  sixteen  percent  (16%)  (rubber,  leather,  and  plastic  wastes)  are
considered  "potentially  biodegradable." That leaves only 19.2% (glass, metals,
and  miscellaneous)  that are not  potentially  treatable  with  bioremediation.
Currently,  only about one percent  (1%) of the total  environmental  management
market is treated using  bioremediation.  Although this is a small percentage of
the  overall  market,  it  represents  over  a  billion  dollar  a  year  market
sub-sector.

     According to a recent BCC study titled "Bioremediation of Hazardous Wastes,
Waste-water,  and Municipal Waste," the value of the U.S.  bioremediation market
in 1998 is  approximately  $1.5  billion and is  projected  to increase to $1.76
billion in 2001,  reflecting  an average  annual  growth  rate  ("AAGR") of five
percent 5%. Predicted U.S.  expenditures on  biotechnology  waste management are
forecasted  to increase  annually  through the turn of the century due to public
involvement  in  environmental  issues and corporate  commitments  to reduce the
amount of toxic exposure in the  environment.  BCC notes that the  biotechnology
waste  management  market  is led by  the  hazardous  waste  sector,  which  has
benefitted  from  recent  technological  advances  that have made it possible to
biodegrade  or otherwise  treat a variety of hazardous  wastes.  This market was
valued at $940  million in 1998 and is expected to increase to $1.05  billion in
2001, an AAGR of six percent (6%).

     The market for  wastewater  bioremediation  was $353 million in 1998 and is
projected  to grow to $374  million  in 2001,  an AAGR of 2.9%.  The  market for
municipal  solid  waste  management  had a 1998  value  of $237  million  and is
expected to be worth $262 million in 2001,  an AAGR of 5.1%.  The  conversion of
waste-to-energy is a $66 million sector of the bioremediation market in 1998 and


<PAGE>



will  account  for  $67  million  in  2001,  an AAGR of  0.8%.  Bio-enzymes  are
inherently  environmentally  preferable products. Since the products digest food
waste and grease a little bit at a time,  they  prevent the need for  acid-based
chemicals,  which can harm pipes and are disapproved by water  treatment  plants
due to their caustic nature.  Municipalities  want food wastes reduced to carbon
dioxide and water before they reach the treatment plants.

FRANCHISING DISTRIBUTION METHOD

The  Company  markets  its  products  through  BSFC  which  plans to grow  using
franchising  as  its  distribution   approach.   The   International   Franchise
Association  ("IFA")  estimates that  franchising  in the U.S.  alone  generated
nearly $1 trillion in retail sales in the year 2000 and provides jobs for some 8
million Americans.

     Franchising  has  evolved as a major means of  business  expansion  in both
American and international  economies.  Purchasing a franchise,  which literally
means "to be free,"  presents the opportunity and freedom for an investor to own
and operate business with many immediate and long range advantages.  Franchising
is a marketing technique, or method of doing business,  whereby a parent company
(franchisor)  grants (via a franchise  agreement)  an  individual  outlet  owner
(franchisee)  the right to market  its  product  and  services  while  using the
parent's name, reputation and marketing techniques.

FRANCHISE & SALES PROGRAM

     BSFC was established in 1998 to market and sell environmental  products and
services.  BSFC's home office is located in Hattiesburg,  Mississippi.  In 1998,
BSFC signed an agreement  with Bio Solutions  International  (of which BSP was a
division  until  March,  2004) to market  and sell all of BSM's  products  on an
exclusive  basis.  The  products  manufactured  by BSP proved  superior to other
products on the market for  targeting  specific  applications.  BSP's ability to
customize  products  for  specific  applications  proved  invaluable  to  BSFC's
hands-on service approach to the market.

     The  franchise  program is designed  to be a  comprehensive  service  using
Company's products for the treatment and prevention of:

     A. Grease and related  problems  associated with the build up of grease and
     organics in grease traps, drain lines and toilets in cooking establishments
     such as  restaurants,  schools and nursing  homes.  The franchise is simply
     replacing the cost of pumping the grease traps and snaking the drain lines.
     The cost of treating  the grease  traps and drain lines with the  Company's
     products is normally  much less than the  conventional  pumping and snaking
     method. The cost savings, elimination of the foul odors through accelerated
     bacteria  decomposition,  and the opportunity for the client to participate
     in the conservation of our environment offers little (if any) resistance to
     the sale.  The  Company  treatment  service  has proved so  successful  the
     franchisee  is able to  guarantee  the owner or  manager  that in the event
     there is a need to pump, he (the franchisee) will absorb the cost.

     B.  Municipal  Waste  Treatment  Plants and Sewage Lift  Stations:  As real
     estate  development and the industrial  expansion continue at a rapid rate,
     the once  remote  locations  of the  municipal  collection  systems are now
     becoming surrounded with subdivisions, shopping centers and small


<PAGE>



     businesses.   The  outcry  to  eliminate  and  control  the  pungent  odors
     associated with these treatment plants is being exercised  through lawsuits
     and  community  action  groups  at  an  alarming  rate.  The  citizens  are
     struggling with the foul odors and  municipalities  are struggling with the
     high and  increasing  cost of  maintaining  the lift stations and treatment
     plants because of the amount of grease released into the sewage conduits.

     The  Company's  bacteria has proven to be a very cost  effective  method of
controlling  odors and  eliminating  sewage waste  associated with the treatment
plants and  maintaining  the lift  stations.  This  affords  the  franchisee  an
opportunity to work with the municipalities to address these problems and create
a  favorable   environment  to  promote  the  use  of  these  products  for  the
restaurants,  schools,  nursing  homes and  other  cooking  establishments.  The
franchisee  earns his income  through the sale of  products  and the sale of his
services that include the use of the Company's products. The franchisee buys his
products from BSFC.

COMPETITION

     The principal  markets in which the Company  competes are  competitive  and
fragmented,  with  competitors  in the  environmental  services  market  and the
bioremediation  market sub-sector.  Increased  competition could have a material
adverse effect on the Company, as competition may have far greater financial and
other  resources   available  to  them  and  possess  extensive   manufacturing,
distribution  and marketing  capabilities far greater than those of the Company.
Although   all  future   employees   are   expected   to  be  required  to  sign
confidentiality  agreements,  there is no  guarantee  either that trade  secrets
won't be  shared  with  competitors  or that the  Company  could  enforce  these
agreements.  Such  disclosures,  if made, could negatively  affect the Company's
competitiveness.  The markets the Company serves are highly competitive and many
competitors  have  much  greater   resources.   Many  of  the  competitors  have
substantially  greater  financial,  technical  and marketing  resources,  larger
customer bases,  longer operating  histories,  greater name recognition and more
established relationships in the industry than Bio-Solutions International, Inc.

SOURCES AND AVAILABILITY OF RAW MATERIALS AND PRINCIPAL SUPPLIERS

     The  Company  obtains  all its raw  materials  for the  manufacture  of its
products from other sources.  The Company generally does not have contracts with
any  entities or persons  committing  such  suppliers  to provide the  materials
required for the  production  of its  products.  There can be no assurance  that
suppliers will provide the raw materials needed by the Company in the quantities
requested or at a price the Company is willing to pay.  Because the Company does
not control the actual production of these raw materials,  it is also subject to
delays caused by interruption in production of materials based on conditions not
wholly  within its  control.  The  inability  of the Company to obtain  adequate
supplies of raw materials for its products at favorable  prices, or at all, as a
result of any of the  foregoing  factors  or  otherwise,  could  have a material
adverse effect on the Company.

INTELLECTUAL PROPERTY

     The Company's  products,  formulas and processes are  proprietary and owned
it. The  Company's  employees  associated  with and  involved in any part of the
research/manufacturing


<PAGE>



process  have  signed  non-disclosure/confidentiality  agreements  in  order  to
prohibit them from using any part of the  technology  developed and owned by the
Company.

GOVERNMENTAL REGULATION

     None. The Company's products are derived from naturally  occurring bacteria
and enzymes, which are environmentally friendly.

RESEARCH & DEVELOPMENT

     The Company's  products were  developed  based on several years of research
work  carried out in  International  Media and Culture  laboratories  at Salida,
Colorado,  followed by the work at Orchard and Superior,  Nebraska Laboratories.
After  purchasing  the  technology  from  IMAC,  the  Company  is  strengthening
different  products  through  a  research  and  development   program  with  its
facilities  and  research  staff  located  permanently  at its  headquarters  in
Hattiesburg, Mississippi.

COMPLIANCE WITH ENVIRONMENTAL LAWS

     Some  municipalities  have  restrictions on enzyme use in grease traps. The
Company  uses  bacteria  and  enzymes  and has,  to date,  been  able to  obtain
exemptions for such use.

PERSONNEL.

     As of October  31,  2004,  the  Company  had four  employees.  One  officer
received  compensation  of $72,000.  The other officer and the directors  served
without  compensation  of any kind. The employees are not represented by a labor
union for purposes of collective bargaining. The Company considers its relations
with its  employees  to be  excellent.  The Company  plans to employ  additional
personnel as needed.



ITEM 2. DESCRIPTION OF PROPERTY.

     The Company's  principal place of business is located at 1161 James Street,
Hattiesburg,  Mississippi, 39401, which it leases, by assignment from BSII, from
an entity controlled by related parties. The lease will expire on April 30, 2007
with an annual rental of $36,000.  The leased premises are approximately  12,000
square feet of usable  space.  The Company uses the space both as its  corporate
headquarters  and to manufacture  and  distribute its products.  The term of the
lease is for a period of five years.  The Company owns no real  property and its
personal  property  consists of furniture,  fixtures and  equipment  with a book
value of $378,788 on October 31, 2004.


ITEM 3. LEGAL PROCEEDINGS.


     During the fiscal year ended  October 31,  2003,  the  predecessor  company
(whose  operations  and  results  are not  reflected  in the  operations  of the
Company),  Arnold Sock and Martin Becker were  defendants in litigation that had
been filed by William Eisen and William Brown in Los Angeles



<PAGE>



County  Superior Court on June 27, 2001.  The plaintiffs  alleged that they were
entitled to a finder's  fee in the amount of  $250,000  from the  defendants  in
connection with the Company's  acquisition of SSET The litigation was settled in
November  2003 by the  Company's  payment of $5,000 in cash and the  issuance of
1,400,000 (pre-reverse split) shares of common stock.


ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

     On September  22,  2003,  the Company  obtained the written  consent of the
holders of 72,056,987 shares of its common stock to a 1-for-100 reverse split of
the Company's  outstanding common stock. Such shares  constituted  approximately
72.1% of the Company's  outstanding shares. An Information  Statement describing
the action was mailed to the Company's  shareholders  on or about  September 11,
2003.



                                     PART II


ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.

     MARKET  INFORMATION.  The  Company's  common  stock  is  quoted  on the OTC
Bulletin  Board  under the symbol  "BSLM."  The  following  table sets forth the
quarterly  high and low bids for the  Company's  common stock as reported by the
OTC Bulletin Board for the past two fiscal years:

Fiscal Year 2003              High*       Low*
First Quarter                 $2.00       $0.50
Second Quarter                $9.00       $1.00
Third Quarter                 $2.50       $1.00
Fourth Quarter                $2.00       $1.05

Fiscal year 2004
First Quarter                 $2.00       $1.35
Second Quarter                $2.40       $0.80
Third Quarter                 $3.40       $0.80
Fourth Quarter                $2.30       $0.80

-------------------------------------------
*    These  quotations  reflect  inter-dealer  prices,  without retail  mark-up,
     mark-down or commission,  and may not represent  actual  transactions.  All
     prices  adjusted  to reflect a  1-for-100  reverse  stock split that became
     effective on October 2, 2003.

     SHAREHOLDERS.  As of February 9, 2005, there were 1528 holders of record of
the Company's common stock.

     DIVIDEND  POLICY.  The Company has never declared or paid cash dividends on
its common  stock and  anticipates  that all future  earnings,  if any,  will be
retained  as working  capital  and for  business  expansion.  The payment of any
future dividends will be at the sole discretion of the


<PAGE>



Board of  Directors  and will depend upon,  among other  things,  the  Company's
future  earnings,  capital  requirements  and  financial  condition,  as well as
general business  conditions.  There can be no assurance that any cash dividends
will ever be paid on the common stock.

RECENT SALES OF UNREGISTERED SECURITIES.


     In December,  2004, the Company issued 1,543,985 shares of its common stock
to four  non-affiliated  parities in  accordance  with the  provisions of a Debt
Conversion  Agreement  that provided that in exchange for funds  advanced to the
Company,  the Lender would accept the number of shares of the  company's  common
stock determined by dividing the amount advanced by Twenty-five ($0.25) cents in
full  satisfaction  of the  company's  obligation  to repay  the  advances  plus
interest at the rate of seven and one-half(7  1/2%) per year.  These shares were
issued in  reliance  on Section  4(2) of the  Securities  Act of 1933  ("Section
4(2)").

     In January,  2005,  the Company  privately  issued 100,000 shares of common
stock to a non-affiliated  party, for the sum of $50,000 advanced to the Company
in  September,  2004.  The  issuance was made in reliance on Section 4(2) of the
Securities Act of 1933 ("Section 4(2)").

     In January,  2005,  the Company  privately  issued 300,000 shares of common
stock to a non-affiliated party, for the sum of $130,000 advanced to the Company
in  September,  2004.  The  issuance was made in reliance on Section 4(2) of the
Securities Act of 1933 ("Section 4(2)").

     In February,  2005,  the Company  privately  issued 25,000 shares of common
stock to non- affiliated party, for the sum of $25,000,  plus, for a period of 2
years form the date of issue, the right to purchase an additional  25,000 shares
of common  stock at a price equal to $1.50 per share.  The  issuance was made in
reliance on Section 4(2) of the Securities Act of 1933 ("Section 4(2)").



ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

THIS SECTION CONTAINS FORWARD-LOOKING STATEMENTS, INCLUDING STATEMENTS REGARDING
THE COMPANY'S  PROSPECTS FOR  CONTINUED  OPERATION AND EXISTENCE AND  STATEMENTS
REGARDING THE COMPANY'S PLANS,  OBJECTIVES,  EXPECTATIONS AND INTENTIONS.  THOSE
FORWARD-LOOKING  STATEMENTS ARE BASED ON MANAGEMENT'S  CURRENT  EXPECTATIONS AND
ARE  SUBJECT  TO A NUMBER OF RISKS,  FACTORS  AND  UNCERTAINTIES  THAT MAY CAUSE
ACTUAL RESULTS,  EVENTS AND PERFORMANCE TO DIFFER MATERIALLY FROM THOSE REFERRED
TO IN THE  FORWARD-LOOKING  STATEMENTS.  THOSE RISKS,  FACTORS AND UNCERTAINTIES
INCLUDE,  BUT  ARE  NOT  LIMITED  TO,  THE  COMPANY'S  HISTORY  OF  NET  LOSSES,
UNCERTAINTY AS TO THE AVAILABILITY OF REQUIRED FUNDING AND UNCERTAINTY AS TO THE
COMPANY'S ABILITY TO MAINTAIN OPERATIONS AT ANY LEVEL. THE CAUTIONARY STATEMENTS
MADE IN THIS  SECTION  SHOULD BE READ AS BEING  APPLIED TO ALL RELATED  FORWARD-
LOOKING STATEMENTS WHEREVER THEY APPEAR IN THIS DOCUMENT.


<PAGE>



     QUALIFIED REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS. The Company's
independent  accountant  has  qualified  his  report,  stating  that the audited
financial  statements  of the Company for the fiscal year ended October 31, 2003
and 2004 have been  prepared  assuming  the  Company  will  continue  as a going
concern. The independent accountant notes that the Company's continued existence
is dependent upon its ability to generate  sufficient cash flows from operations
to support its daily  operations,  as well as provide  sufficient  resources  to
retire existing liabilities and obligations on a timely basis.


     DISCONTINUED  OPERATIONS.  The Company previously  acquired SSET, which was
accounted  for as a reverse  acquisition.  After a  dispute  arose  between  the
Company and the seller of SSET that resulted in the SSET Settlement, the Company
continued to pay the ongoing operational expenses of SSET (such as its rent) and
invested additional money in an attempt to generate a new revenue stream through
new business.  This attempt  proved  unsuccessful  and SSET's  business plan was
abandoned.  As a result, the financial statements treated SSET as a discontinued
operation.




<PAGE>




RESULTS OF CONTINUING OPERATIONS FOR THE FISCAL YEARS ENDED OCTOBER 31, 2004 AND
OCTOBER 31, 2003.

     REVENUES.  Revenues from  continuing  operations  for the fiscal year ended
October 31, 2004 were  $191,372  and for the fiscal year ended  October 31, 2003
were $411,390.The decrease of $220,018, or 53% is due to reduced franchise sales
and product and service revenues.

     COST OF REVENUES.  Cost of revenue from continuing  operations was $141,029
for the fiscal year ended  October 31, 2004,  a decrease of $3,110,  or 2%, from
the $144,139 for the fiscal year ended October 31, 2003.

     GROSS PROFIT.  The gross profit from  continuing  operations for the fiscal
year ended  October 31, 2004 was $50,343 and  $267,251 for the fiscal year ended
October 31, 2003.  The  reduction of $216,908,  or 81% is largely due to reduced
franchise sales, and additional production costs subsequent to the acquisition.

     SELLING,  GENERAL AND ADMINISTRATIVE EXPENSES. The expenses for fiscal year
ended  October 31, 2004 were  $655,931.  The  Company's  expenses  increased  by
$368,531,  up 128% during the fiscal year ended  October 31,  2004,  compared to
2003 levels of  $287,580.  The  Company's  expenses  were made up  primarily  of
general overhead and expenses incurred in connection with the reorganization and
acquisition and amortization of product formulation costs.

     NET  LOSSES  FROM  CONTINUING  OPERATIONS.  The  Company  had a net loss of
$635,795  for the year ended  October 31,  2004,  as compared to $66,524 for the
fiscal year ended  October  31,  2003.  The loss for the year ended  October 31,
reflects  the  lower  sales  and  reduced  profit  margins  and  the  impact  of
acquisition expenses.

     LIQUIDITY AND CAPITAL  RESOURCES.  As of October 31, 2004,  the Company had
cash of  $66,923,  and total  current  assets  of  $92,127  and total  assets of
$640,852.  The Company's  current and total  liabilities  were  $1,200,223 as of
October 31,  2004.  Net funds for the year of $31,472  were  provided by sale of
common  stock of $375,000,  net loans of  $783,888,  and an increase in accounts
payable of $151,740.  Funds were used for the net loss  (excluding  depreciation
and amortization) of $514,099, the acquisition and related costs of $734,339 and
fixed asset purchases of $64,574.

     For the year ended October 31, 2003, the $35,451 increase in net funds were
provided  by   increases  in  payables  and  accruals  of  $71,469  and  accrued
compensation of $64,451 and reductions in inventory of $51,601.  Funds were used
for loan repayments of $72,620, fixed asset purchases of $31,715 and an increase
in accounts receivable of $34,475.



<PAGE>

ITEM 7. FINANCIAL STATEMENTS.



TABLE OF CONTENTS
--------------------------------------------------------------------------- ----

                                                                            Page

Report of Independent Registered Public Accounting Firm                     F- 2

    Balance Sheet                                                           F- 3

    Statements of Operations                                                F- 4

    Statements of Stockholders' Deficiency                                  F- 5

    Statements of Cash Flows                                                F- 6

    Notes to Consolidated Financial Statements                              F- 7


-------------------------------------------------------------------------------







<PAGE>



                              BAUM & COMPANY, P.A.
                          Certified Public Accountants
                        1515 University Drive, Suite 226
                          Coral Springs, Florida 33071

             REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders
Hattiesburg, Mississippi

We have audited the accompanying  balance sheet of Bio Solutions  Manufacturing,
Inc. (formerly Single Source Financial  Services  Corporation) as of October 31,
2004 and the related  statements of operations,  stockholders'  equity (deficit)
and cash flows for the years ended  October 31, 2004 and 2003.  These  financial
statements   are  the   responsibility   of  the   Company's   management.   Our
responsibility  is to express an opinion on these financial  statements based on
our audits.

We conducted our audits in accordance  with the standards of the Public  Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement.  An audit includes examining, on a
test basis,  evidence supporting the amounts and disclosures in the consolidated
financial statements. An audit also includes assessing the accounting principles
used and  significant  estimates made by  management,  as well as evaluating the
overall financial statement  presentation.  We believe that our audits provide a
reasonable basis for our opinion.

The above mentioned  statement of operations and cash flows statements have been
restated to reflect October 31, 2004 and 2003 for a full twelve month period and
for the accounting as a reverse acquisition. (See note 18).

In our opinion,  the financial  statements  referred to above present fairly, in
all material  respects,  the financial  position of Bio Solutions  Manufacturing
Inc. (formerly Single Source Financial Services  Corporation ) as of October 31,
2004 and the  results  of their  operations  and their  cash flows for the years
ended  October  31, 2004 and 2003 in  conformity  with U.S.  generally  accepted
accounting principles.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company will continue as a going  concern.  As discussed in Note 14, the Company
is  experiencing  difficulty  in  generating  sufficient  cash  flow to meet its
capital  requirements and sustain  operations,  which raises  substantial  doubt
about its ability to continue as a going  concern.  The financial  statements do
not  include  any  adjustments  that  might  result  from  the  outcome  of this
uncertainty.

BAUM & COMPANY, P.A.
Coral Springs, Florida
February 11, 2005, except  for: notes 17 and note 18 November 21, 2005.




                                       F-2
<PAGE>


<TABLE>
<CAPTION>
                        Bio Solutions Manufacturing Inc.
                           Consolidated Balance Sheet
                                October 31, 2004


<S>                                                                             <C>
                            ASSETS

 CURRENT ASSETS

       Cash                                                                     $             66,923
       Inventory                                                                              25,204
                                                                                --------------------

             Total current assets                                                             92,127

 PROPERTY AND EQUIPMENT (Net of accumulated depreciation of $ 102,758)                       378,788

 OTHER NON-CURRENT ASSETS
        Product Formulation ( Net of $ 83,333 amortization)                                  166,667
         Security Deposit                                                                      3,000
                                                                                --------------------
             Total non-current assets                                                        169,667
                                                                                --------------------

 Total assets                                                                   $            640,582
                                                                                ====================

      LIABILITIES AND STOCKHOLDERS' DEFICIENCY

 CURRENT LIABILITIES
       Accounts Payable and Accruals                                            $            461,335
       Loans Payable - Affiliated Company                                                     55,000
       Loans Payable                                                                          50,000
       Loan Payable -Related Party                                                           633,888
                                                                                --------------------

             Total Current Liabilities                                                     1,200,223
                                                                                --------------------

 Total Liabilities                                                                         1,200,223
                                                                                --------------------

 STOCKHOLDERS' EQUITY (DEFICIENCY)
       Preferred Stock,  no par value, 10,000,000 authorized,
          none issued and outstanding                                                              -
       Common stock $0.001 par value, 100,000,000
      authorized,  14,465,243 shares  issued and outstanding                                  14,465
       Additional paid in capital                                                            634,717
        Accumulated Deficit                                                               (1,208,823)
                                                                                --------------------

             Total stockholders' equity (deficit)                                           (559,641)
                                                                                --------------------

 Total liabilities and stockholders' equity                                     $            640,582
                                                                                ====================
</TABLE>

    The accompanying notes are an integral part of the financial statements.


                                      F-3
<PAGE>


<TABLE>
<CAPTION>
                        Bio Solutions Manufacturing Inc.
                      Consolidated Statement of Operations
                 For the Years ending October 31, 2004 and 2003

                                                                                        2004                2003
                                                                               ------------------ -------------------
<S>                                                                             <C>               <C>
 REVENUES
       Sales of franchises                                                      $          12,501 $           108,576
       Product and service sales                                                          178,871             302,814
                                                                               ------------------ -------------------

             Total revenues                                                               191,372             411,390

 COST OF GOODS SOLD                                                                       141,029             144,139
                                                                               ------------------ -------------------

             Gross profit                                                                  50,343             267,251

 OPERATING EXPENSES                                                                       655,931             287,580
                                                                               ------------------ -------------------

             Total operating expenses                                                     655,931             287,580
                                                                               ------------------ -------------------

 Net income (loss) before other income (expenses) and
 provision for income taxes                                                              (605,588)            (20,329)
                                                                               ------------------ -------------------

 OTHER INCOME (EXPENSE)
       Interest  income/(expense)                                                         (30,207)            (46,195)
                                                                               ------------------ -------------------

             Total other income (expense)                                                 (30,207)            (46,195)
                                                                               ------------------ -------------------

 Net income (loss) before provision for income taxes                                     (635,795)            (66,524)

 Provision for income taxes                                                                     -                   -
                                                                               ------------------ -------------------

 Net income (loss)-Continuing Operations                                                 (635,795)            (66,524)

 (LOSS) FROM DISCONTINUED OPERATIONS                                                      (20,756)           (269,713)
                                                                               ------------------ -------------------

 Net income (loss)-Continuing Operations                                        $        (656,551)$          (336,237)
                                                                               ================== ===================

 Net income (loss) per weighted average share-continuing operations                        ($0.05)             ($0.00)
                                                                               ================== ===================
 Net income (loss) per weighted average share-discontinued  operations                     ($0.00)             ($0.02)
                                                                               ================== ===================
 Weighted average number of shares                                                     14,001,287          14,001,287
                                                                               ================== ===================
</TABLE>

    The accompanying notes are an integral part of the financial statements.


                                      F-4
<PAGE>



<TABLE>
<CAPTION>
                         Bio Solutions Manufacturing Inc
                 Consolidated Statement of Stockholders' Equity

                                                                              Paid in Capital     Accumulated         Total
                                    Number of       Common      Preferred        in Excess          Deficit       Stockholders'
                                     Shares          Stock        Stock           of Par                              Equity
                                   ------------- ------------ ------------- ------------------ ---------------- -----------------
<S>                                <C>           <C>          <C>           <C>                <C>              <C>
BALANCE, October 31, 2002              1,000,000 $      5,775 $           - $        1,694,508 $     (2,279,931)$        (579,648)
 (predecessor company)

Net loss year ending
  October 31 2003                                                                                      (336,237)         (336,237)

Acquisition adjustments and
  expenses                            12,645,243        7,870                       (1,563,971)       2,043,140           487,039
                                   ------------- ------------ ------------- ------------------ ---------------- -----------------

BALANCE, October 31, 2003             13,645,243       13,645             -            130,537         (573,028)         (428,846)

March 2004 common stock sold
  for $300.000                           150,000          150                          299,850                            300,000
April  2004 $ 300,000 debt
  converted to 500,000 shares            500,000          500                          124,500                            125,000

July  2004 $ 5,000 debt converted
  to 20,000 shares                        20,000           20                            4,980                              5,000

October 2004 common stock sold
  for $75,000                            150,000          150                           74,850                             75,000

Divestment of discontinued
  operations                                                                                            20,756             20,756
Net loss for the year ending
  October 31, 2004                                                                                    (656,551)          (656,551)
                                   ------------- ------------ ------------- ------------------ ---------------- -----------------

BALANCE, October 31, 2004             14,465,243 $     14,465 $           - $          634,717 $     (1,208,823)$        (559,641)
                                   ============= ============ ============= ================== ================ =================
</TABLE>

   The accompanying notes are an integral part of the financial statements.

                                       F-5

<PAGE>


<TABLE>
<CAPTION>
                        Bio Solutions Manufacturing Inc.
                             Statement of Cash Flows
                 For the Years ending October 31, 2004 and 2003



                                                                                        2004                    2003
                                                                                --------------------  --------------------
<S>                                                                             <C>                   <C>
 CASH FLOWS FROM OPERATING ACTIVITIES:
       Net income (loss)                                                        $           (656,551) $           (336,237)

       Adjustments to reconcile net income (loss) to net cash provided
        (used) by operations:
             Common stock issued for services                                                      -                25,000
             Loss from Discontiued Operations                                                 20,756               269,713
             Provision for doubtful accounts                                                       -                 2,932
             Depreciation and amortization                                                   142,452                48,519
             Common Stock Issued for dispute settlement                                            -                 3,750

       Changes in operating assets and liabilities:
             (Increase) decrease in accounts receivable                                        4,323               (34,475)
             (Increase) decrease in inventory                                                 16,764                51,601
              Decrease  in security deposits                                                       -                 2,500
              Increase in accrued compensation, related party                                      -                64,451
             Increase (decrease) in accounts payable and other accruals                      151,740                71,469
             Increase/(decrease) in security deposits                                         (3,000)                    -
             (Increase) decrease in prepaid franchise sale income                                  -               (18,193)
                                                                                --------------------  --------------------
 Net cash provided (used) by operating activities                                           (323,516)              151,030

 CASH FLOW FROM INVESTING ACTIVITIES:
       Purchase of fixed assets                                                              (64,574)              (31,715)
                                                                                --------------------  --------------------
 Net cash provided (used) by investing activities                                            (64,574)              (31,715)

 CASH FLOW FROM FINANCING ACTIVITIES:
         Payments on capitalized lease                                                             -                  (716)
         Payments of loans-other                                                             (45,000)              (72,620)
         Expenses and cash used for acquistion                                              (734,339)                    -
         Bank overdraft                                                                       (4,987)              (10,528)
                                                                                --------------------  --------------------
 Net cash provided (used) by financing activities                                            419,562               (83,864)
                                                                                --------------------  --------------------

 Net increase (decrease) in cash                                                              31,472                35,451

 CASH - BEGINNING                                                                             35,451                     -
                                                                                --------------------  --------------------

 CASH - ENDING                                                                  $             66,923                35,451
                                                                                ====================  ====================
 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
 Cash paid for interest expense                                                 $                  -  $                  -
                                                                                ====================  ====================
 Cash paid for income taxes                                                     $                  -  $                  -
                                                                                ====================  ====================
  Stock issued to retire debt                                                   $                  -  $              3,750
                                                                                ====================  ====================
</TABLE>

In March 2004, 150,000 shares of common stock was issued for $300,000.

In April 2004, $ 125,000 of debt was  converted  into  500,000  shares of common
stock.

In July 2004, $ 5,000 of debt was converted into 20,000 shares of common stock

In October 2004, 150,000 shares of common stock was issued for $ 75,000.

    The accompanying notes are an integral part of the financial statements.

                                      F-6

<PAGE>



BIO SOLUTIONS MANUFACTURING, INC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2004

Note 1 - Summary of Significant Accounting Policies

Nature of Business and History of Company

Bio  Solutions  Manufacturing,   Inc  .("BSM")  (formerly  named  Single  Source
Financial  Services  Corporation until May 2, 2004) was incorporated in New York
on September 19, 1994 under the name Ream Printing Paper Corp. In November 2000,
the Company acquired Single Source Electronic  Transactions,  Inc. ("SSET").  In
March 1, 2004, it acquired Bio Solutions Production, Inc, (Production) ,formerly
named Bio Solutions  Manufacturing,  Inc. a former manufacturing division of Bio
Solutions International, Inc.

Single  Source  Electronic  Transactions,  Inc.  was in the  business of selling
equipment to merchants used in the electronically processing of payments derived
from sales and assisting  them in  establishing  merchant  accounts with various
financial institutions.

In August  2001,  a dispute  arose  between  the Company and the seller of SSET.
Under the terms of the settlement,  the seller received the historical  residual
stream  generated  on all  sales  made  prior to July 31,  2001.  For  financial
reporting  purposes,  the Company  treated this  transaction  as a disposal of a
business  segment.  After the  settlement,  the  Company  continued  in the same
business and in 2002 discontinued the operations of SSET.

The Company on March 1, 2004 commenced its  manufacturing  operations  under its
Bio-Solutions Production subsidiary.  Bio-Solutions Manufacturing is a developer
and manufacturer of biological waste remediation  products,  servicing municipal
collection systems and food service facilities

Basis of Presentation

The accounting  presentation  reflects that Production as the acquiring  entity,
having  been merged  into the  reporting  company of SSET The equity of SSET has
been eliminated in consolidation, and all acquisition adjustments are reflective
of Production. For comparability, the statement of operations and cash flow, for
the year ending  October 31, 2003 of Bio Solutions  International  Inc. has been
presented as the predecessor corporation.

Basis of Accounting

The Company's  financial  statements  are prepared  using the accrual  method of
accounting.

Property and Equipment

Property and equipment are stated at cost.  Major renewals and  improvements are
charged to the asset accounts while replacements, maintenance and repairs, which
do not improve or extend the lives of the respective  assets,  are expensed.  At
the time property and equipment are retired or otherwise  disposed of, the asset
and related  accumulated  depreciation  accounts are relieved of the  applicable
amounts.  Gains or losses from  retirements  or sales are credited or charged to
income.




                                      F-7
<PAGE>



The Company  depreciates  its property  and  equipment  under the  straight-line
method as follows:

       Furniture                           5 years
       Office equipment                    5 years
       Machinery and equipment             5 years
       Leasehold improvements             10 years

In August 2001,  SFAS No. 144,  "Accounting  for the  Impairment  or Disposal of
Long-Lived   Assets,"  was  issued   establishing   new  rules  and   clarifying
implementation  issues  with SFAS No. 121,  "Accounting  for the  Impairment  of
Long-Lived  Assets and for  Long-Lived  Assets to be Disposed of," by allowing a
probability-weighted  cash flow  estimation  approach to measure the  impairment
loss of a long-lived  asset.  The statement also  established  new standards for
accounting for discontinued operations.  Transactions that qualify for reporting
in  discontinued  operations  include the disposal of a component of an entity's
operations  that  comprises  operations  and  cash  flow  that  can  be  clearly
distinguished, operationally and for financial reporting purposes, from the rest
of the entity.  The Company has adopted  this  standard  and its adoption had no
significant effect on the Company's financial statements.

Net Loss Per Share

The  Company  adopted  the  provisions  of  Statement  of  Financial  Accounting
Standards  ("SFAS")  No. 128,  "Earnings  Per Share"  ("EPS")  that  established
standards  for the  computation,  presentation  and  disclosure  of earnings per
share,  replacing the  presentation  of Primary EPS with a presentation of Basic
EPS.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers cash and cash
equivalents to include all stable,  highly liquid investments with maturities of
three months or less.

Accounting Estimates

Management uses estimates and assumptions in preparing  financial  statements in
accordance with generally accepted  accounting  principles.  Those estimates and
assumptions  affect  the  reported  amounts  of  assets  and  liabilities,   the
disclosure of contingent  assets and liabilities,  and the reported revenues and
expenses. Actual results could vary from the estimates that were used.

Income Taxes

The Company  accounts for its income taxes under the  provisions of Statement of
Financial  Accounting  Standards 109 ("SFAS 109").  The method of accounting for
income  taxes  under SFAS 109 is an asset and  liability  method.  The asset and
liability method requires the recognition of deferred tax liabilities and assets
for the expected future tax  consequences of temporary  differences  between tax
bases and financial reporting bases of other assets and liabilities.

Fair Value of Financial Instruments

Pursuant  to  SFAS  No.  107,   "Disclosures   About  Fair  Value  of  Financial
Instruments",  the  Company  is  required  to  estimate  the  fair  value of all
financial  instruments included on its balance sheet as of October 31, 2004. The
Company considers the carrying value of such amounts in the financial statements
to approximate their face value.


                                      F-8
<PAGE>


Revenue  Recognition - Continuing Operations

Revenue is recognized  upon product  shipment FOB.  Additionally,  Bio Solutions
International,  Inc. (the predecessor company) had received income from the sale
of its franchises for exclusive  rights for specific  geographical  territories.
This income was  recognized  upon  receipt due to the  uncertainty  of franchise
continuation.  With the reorganization of the companies, the only future revenue
will be product sales.

Revenue and Commission Expense Recognition - Discontinued Operations

Income from equipment sales was recognized after the buyer received its merchant
and  terminal  identification  numbers  and  was  approved  for  any  applicable
financing.  Income from residuals was recognized  when the residual  payment was
actually received.

The Company  recognized  commissions  owed upon the actual receipt of payment on
the related sale.

Principles of Consolidation

The  consolidated  financial  statements  include the accounts of Bio  Solutions
Manufacturing,  Inc. and its wholly owned subsidiaries  Single Source Electronic
Transactions,  Inc. and Bio-Solutions Production Inc. All material inter-company
accounts and transactions have been eliminated.

Concentration of  Risk

The only  customer for its products is Bio Solution  International,  Inc,  which
resells product exclusively to its' franchisees.

Reclassification

Certain  amounts  in  2003  have  been  reclassified  to  conform  to  the  2004
presentation.  Such  reclassification  had no effect on net income as previously
reported.


Note 2 - Loans Receivable and Payable - Discontinued operations

The Company in  accordance  with the  reorganization  agreement  merged with the
predecessor  company SSFS.  As a result it was deemed that all loans  receivable
and  payable  will be  effectively  assumed by SSET and spun out to the  control
shareholders.


Note 3 - Property and Equipment

Depreciation charged to operations  was $50,786

At October 31, 2004 property and equipment consisted of the following:

          Office furniture and equipment                 $     25,000
          Machinery and equipment                             206,546
          Leasehold improvements                              250,000
                                                         ------------
                                                              481,546
         Accumulated Depreciation                            (102,758)
                                                         ------------
                  Net Property and Equipment             $    378,788
                                                         ------------


                                      F-9
<PAGE>



Note 4 - Loan Payable - Related Parties

As of  October  31,  2004,  the  Company  has a balance  due a related  party of
$633,888. This is subject to the terms of a debt conversion agreement. Under the
terms  of  the   agreement,   the  amounts   received  are  assessed   interest,
retroactively,  at a rate of 7.5% per annum and the total  outstanding  balance,
including  accrued  interest,  is  convertible  into shares of common stock at a
conversion price of $.25 per share. See note 7 for loan conversions.

The company has a $225,000  related  party loan that bears  interest at 5% until
assignment in July 2005 and has no maturity. See note 17.

Note 5 - Product Formula

The  Company  as  a  result  of  the  acquisition  of  manufacturing  assets  of
Bio-Solutions International, Inc. had a step in value of its capitalized product
formulas.  Upon  inception of the  Company,  a value of $ 50,000 was assigned to
this  assets  as a result  of a  purchase  from the  outside  party  exclusively
producing  the  product.   Over  the  years,  various  costs  for  research  and
developments   have  been  expensed  to  operations.   Additionally,   many  new
reformulations  of  the  product  have  occurred  and  new  products  have  been
developed.  As a  result  of the  reorganization  in  March  2004,  based on the
consideration a value of $ 250,000 was assigned to the product  formulation.  It
has  been  ascertained,  that the  stated  value of $  250,000  for the  product
formulation will amortized over three years. The amortization for the period was
$ 91,666.

Note 6 - Discontinued Operations

As indicated  above,  the Company  transferred  the residual  stream of merchant
accounts to the former owner of SSET. The Company accounted for this transaction
as a  disposal  of  a  segment  of  its  operations.  Losses  from  discontinued
operations for the year ended October 31, 2004 was $ 20,756.

Note 7 - Stockholders' Equity

Preferred Stock:

As of  October  31,  2004,  the  Company  had  authorized  10,000,000  shares of
preferred stock. There were no shares issued or outstanding.

The holders of preferred stock have certain preferential rights over the holders
of the Company's  common shares.  Dividend  features or voting rights are at the
discretion  of the Board of Directors  without the  requirement  of  shareholder
approval.

Common Stock

As of October 31, 2004, the Company had authorized  100,000,000 shares of common
stock of which 14,465,243 are issued and  outstanding.  The company was formerly
the manufacturing division of "BSII". The assets and related assumed liabilities
as a result of this acquisition of the  manufacturing  division formed the basis
of the company's initial balance sheet along with the SSFS reorganization.

The holders of the Company's  common stock are entitled to one vote per share of
common stock held.

In October 2003, the company carried out a 1 for 100 reverse split of its common
stock. All related per share information has been restated, accordingly.


                                      F-10
<PAGE>


In March 1, 2004,  12,645,000  shares of common stock were issued for all of the
common stock of Bio Solutions Production,  Inc.  ("Production"),  formerly named
Bio  Solutions   Manufacturing,   Inc,  a  former   division  of  Bio  Solutions
International  Inc. The Company will also replace the warrants of  "Production",
with its  warrants,  expiring in January 31, 2007 to purchase the same number of
the Company's  common stock of 450,000 shares with similar terms. The shares and
warrants of the Company to be exchanged  will be placed in escrow and subject to
an escrow agreement.

As  part  of the  stock  exchange,  shareholders  invested  $667,600  in cash in
"Production  "  Additionally,  as of July 31, 2004,  the company has $ 40,000 of
stock subscriptions receivables from the former shareholders of "Production ".

In March 2004,  the company  sold  150,000  shares of common stock for $2.00 per
share and received $300,000. This was subsequently amended in July 2005, to $.50
per share, and the $225,000  modification  was recorded as a loan payable,  This
loan was assigned to a related party.

On April 7, 2004  $125,000  of debt was  converted  to 500,000  shares of common
stock. On July 29, 2004, $5,000 of debt was converted to 20,000 shares of common
stock.

The Company  issued 14,000 shares of its common stock in  consideration  for the
settlement  of a lawsuit  that were valued at  $14,000.  See Note 11 for further
details.

All  issuances  of the  Company's  stock for  non-cash  consideration  have been
assigned a dollar  amount  equaling the market value of the shares issued on the
respective stock issuance or the value of consideration  received,  whichever is
more readily determinable.


Note 8 - Subsidiary Acquisition

On March 18, 2004, the company, via a stock exchange,  acquired the common stock
of Bio  Solutions  Production,  Inc.  ("Production"),  a former  division of Bio
Solutions International Inc. The net assets acquired include:

                  Fixed Assets                $ 350,000
                  Product Formulas              250,000
                  Inventory                      41,968
                  Payables                     (359,708)

As part of the stock exchange, shareholders invested  $667,600  in "Production"


Note 9 - Employee Stock Plan

On April 19,  2002,  the Company  formed the Bio  Solutions  Manufacturing  Inc.
(formerly Single Source Financial Services  Corporation) 2002 Omnibus Securities
Plan.  Under the plan,  the Company may grant options or issue stock to selected
employees,  directors,  and  consultants  for up to 30,000 shares.  The exercise
price of each option is at the  discretion of the Board of Directors but can not
be less than 85% of the fair market  value of a share at the date of grant (100%
of fair market value for 10%  shareholders).  The vesting  period of each option
granted is also at the  discretion  of the Board of  Directors,  but each option
granted shall vest at a rate of no less than 20% per year from date of grant. As
of October 31, 2004, no options have been granted.


                                      F-11
<PAGE>



Note 10.  Income Taxes

The provisions for income taxes for the year ended October 31, 2004 consisted of
the following:

 Provision(benefit) for income taxes               $ 191,600
  at statutory federal rate,
 Valuation Allowance                                (191,600)
                                                   ---------
  Net Income Tax Provision                         $       -
                                                   =========

The  reported  provision  for income taxes  differs from the amount  computed by
applying the statutory  U.S.  federal  income tax rate of 34% to the loss before
income taxes as follows:

                                                   October 31, 2004
                                                   ----------------
Federal income taxes at statutory rate                      34%
State tax rate, net of federal income tax                    3
Valuation Allowance                                        (37)
                                                         ------
   Effective income tax rate                                 0%
                                                         ======

Due to net operating  losses and the uncertainty of realization,  no tax benefit
has been recognized for operating  losses.  The Company's ability to utilize its
net operating loss  carryforwards is uncertain and thus a valuation  reserve has
been provided against the Company's net deferred tax assets.

At October 31, 2004 the Company has unused net operating losses of approximately
$ 562,000  (which  begin  expiring in 2019) that may be applied  against  future
taxable income.


Note 11 - Commitments and Contingencies

Settlement of Lawsuit

As described in Note 7, the Company  issued 14,000 shares of its common stock in
consideration  for the settlement of a lawsuit that were valued at $14,000.  The
former  President  of the Company and a spouse of a former  Director  ("Spouse")
guaranteed  that the  shares of common  stock  would be worth at least  $100,000
within  three  years.  If the  holders of these  shares are not able to sell the
common stock for $100,000 within three years, then the President and Spouse will
be liable for the  difference  between  what the shares could of sold for during
those three years and the  $100,000.  If these  individuals  are required to pay
this liability,  then Bio-Solutions  Manufacturing,  Inc. ("BSM") will cause the
Company to  indemnify  and pay the former  President  and the former  Spouse any
amounts they are required to pay under the settlement.

Spin-Off Agreement

On January 15, 2004 the Company and its wholly owned subsidiary SSET,  signed an
agreement  to  divide  the  existing   businesses  so  that  SSET  will  operate
independent  of the  Company  and to  distribute  as a  dividend  to the  common
shareholders  of the  Company all the  outstanding  common  shares of SSET.  The
Company  expects  this  spin-off to be a tax-free  distribution  under  Internal
Revenue Code Section 355.


                                      F-12
<PAGE>


Ten days prior to the distribution  date, the SSET will transfer 1,000 shares of
its common stock to the Company for all of the Company's  shares of common stock
in CardReady of New York,  Inc. and SSFS Merchant  Services,  Inc. Also prior to
the  distribution  date, the Company and SSET, at SSET's  expense,  will file to
request SSET's common stock be quoted on the OTC Bulletin Board. The Company and
SSET, at SSET's expense,  will file with the Securities and Exchange  Commission
SSET's  Registration  Statement.  BSM has been  informed  by the Company of this
spin-off  agreement  with SSET.  As of July 31, 2004,  the terms of the Spin-off
Agreement had not yet been consummated.

Upon the  completion  of the SSET  spin-off  each of the  former  Bio  Solutions
Manufacturing  ("BSM") shareholders agrees to transfer all of the shares of SSET
that BSM shareholders received in the spin-off agreement for one dollar.

On March 18, 2004, after the execution of the  reorganization and stock purchase
agreement,  the Company signed a Share Lock-up  Agreement with four shareholders
of BSM who hold 2,050,000 shares of the Company.  These shareholders agreed that
for a period of two years these  shares will be held in escrow and at the end of
two years these shares will be returned to its shareholders.

The Company and SSET have entered into an Option Assignment Agreement with Card
Ready and MBBRAMAR, Inc. ("MBB") on February 12, 2004. Under this agreement the
Company has cancelled its previous exercise of its option to purchase shares of
Card Ready from MBB. The Company has assigned all of its rights and obligations
under the option to SSET.

On March 18, 2004, all the Company's Directors resigned and BSM's Directors were
elected to fill the vacancies.

The  financial  statements  do  not  reflect  any  operations  of  SSFS  or  its
wholly-owned subsidiary SSET except as discontinued.


Note 12 -Lease Commitments

Effective   March  1,  2004,   the  Company  has  assumed  (from  Bio  Solutions
International Inc.) the lease for the office and warehouse facilities at its Bio
Solutions  Production  Inc.  subsidiary  for a term  expiring in May 2007.  Rent
expense for the nine months ending October 31, 2004 was $ 36,000. Future minimum
annual  rentals are: 2005 $ 36,000,  2006 $36,000 and 2007  $12,000.  The leased
facilities are owned by individuals that are considered  related parties.  It is
ascertained  that the Company is paying  rent based on the fair market  value of
real estate in its geographic area.


Note 13 - Loan Payable - Affiliated Company

As a result of the asset purchase  agreement dated March 8, 2004, a loan payable
due to "BSII" was incurred for the unpaid  balance of $ 100,000.  The balance as
of  October  31,  2004 was $  55,000.  This  unpaid  balance  is  unsecured  and
non-interest bearing.


Note 14 -Going Concern

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a going  concern.  Going  concern  contemplates  the
realization of assets and the  satisfaction  of liabilities in the normal course
of business over a reasonable  length of time.  The Company has incurred  losses



                                      F-13
<PAGE>



since inception and has negative cash flows from operations.  For the year ended
October 31, 2004 the Company has incurred net losses from continuing  operations
of $635,795.  The future of the Company is dependent  upon its ability to obtain
additional equity or debt financing and upon future  successful  development and
marketing of the Company's  product.  Management is pursuing  various sources of
equity and debt  financing.  Although  the  Company  plans to pursue  additional
financing,  there can be no  assurance  that the Company  will be able to secure
such financing or obtain financing on terms  beneficial to the Company.  Failure
to secure such financing may result in the Company's  inability to continue as a
going concern.

These  financial  statements  do not  include  any  adjustments  relating to the
recoverability  and  classifications  of  recorded  assets,  or the  amounts and
classification  of liabilities  that might be necessary in the event the Company
cannot continue in existence.


Note 15 - Loans Payable

The company  received a $50,000 loan from a  stockholder  that was  subsequently
converted to equity in the December 2004.


Note 16-Recent Accounting Pronouncements

The FASB recently issued the following statements:

FASB 148 - Accounting for  Stock-Based  Compensation - Transition and Disclosure
and  amendment  of FASB  Statement  No. 123 FASB 150 -  Accounting  for  Certain
Financial Instruments with Characteristics of both Liabilities and Equity.

These FASB  statements  did not have,  or are not  expected to have,  a material
impact on the Company's financial position and results of operations.


Note 17-Subsequent Event

In March 2004,  the company  sold  150,000  shares of common stock for $2.00 per
share and received $300,000. This was subsequently amended in July 2005, to $.50
per share,  and the  $225,000  modification  was recorded as a loan payable that
bears  interest at 5%..This  loan was  assigned to a related  party and is to be
repaid via the Company's  product  deliveries.  The revised loan has no maturity
and the interest terminated upon assignment in July 2005.


Note 18-Restatement

The  statement of  operations  and cash flow  statements  have been  restated to
present  comparable  twelve month  information  for the years ending October 31,
2004 and  2003 and to  reflect  the  accounting  as a  reverse  merger  with Bio
Solutions Manufacturing Inc. as the surviving entity and Single Source Financial
Services as the corporate shell.





                                      F-14
<PAGE>



ITEM 8.  CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING  AND
         FINANCIAL DISCLOSURE.

         None.


ITEM 8A. CONTROLS AND PROCEDURES.


     The Company maintains  disclosure controls and procedures that are designed
to ensure that  information  required to be disclosed in the Company's  Exchange
Act reports is recorded,  processed,  summarized  and  reported  within the time
periods  specified  in the  rules  and  forms  of the  Securities  and  Exchange
Commission   (the  "SEC"),   and  that  such   information  is  accumulated  and
communicated  to the  Company's  management,  including  its President and Chief
Financial Officer, as appropriate,  to allow timely decisions regarding required
disclosure  based on the definition of "disclosure  controls and  procedures" in
Exchange Act Rules 13(a)-15(e) and 15(d)-15(e).  In designing and evaluating the
disclosure controls and procedures,  management recognizes that any controls and
procedures,  no  matter  how  well  designed  and  operated,  can  provide  only
reasonable assurance of achieving the desired control objectives, and management
necessarily  was required to apply its judgment in evaluating  the  cost-benefit
relationship of possible  controls and  procedures.  As of the end of the period
covered  by this  report,  the  Company  carried  out an  evaluation,  under the
supervision and with the  participation of the Company's  management,  including
the Company's President and Chief Financial Officer, of the effectiveness of the
design and operation of the Company's disclosure controls and procedures.  Based
on the foregoing,  the Company's President and Chief Financial Officer concluded
that the Company's disclosure controls and procedures were effective. There have
been no  significant  changes in the  Company's  internal  controls  or in other
factors that could  significantly  affect those internal controls  subsequent to
the date the Company completed its evaluation.  The financial  statements in the
Form 10-KSB/A were revised to present  comparable  twelve month  information for
the years ended October 31, 2004 and October 31, 2003.







<PAGE>


                                    PART III


ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS; COMPLIANCE
        WITH SECTION 16(a) OF THE EXCHANGE ACT.

     DIRECTORS AND EXECUTIVE OFFICERS.  The following table sets forth the names
and ages of the current directors and executive  officers of the Company and the
principal offices and positions with the Company held by each person. Subject to
prior  resignation or removal,  the Company's  directors  serve in that capacity
until the next annual  meeting of  shareholders  or until their  successors  are
elected or appointed and duly qualified.  Officers are appointed by the Board of
Directors and serve in that capacity until resignation or removal.


    Name                         Age          Position
---------------------           ----        --------------------------------
Krish V. Reddy                   75         President and Director
Patricia Spreitzer               50         Chief Financial Officer, Secretary
                                            and Director

     KRISH V. REDDY, PH.D. is the President/CEO of Bio-Solutions  Manufacturing,
Inc. responsible for overseeing both manufacturing and research & development of
BSLM products, in addition to management responsibilities.  He was the President
of  Bio-Solutions  Inc.,  ("BSI",  a BSM  predecessor  company)  a Denver  based
environmental  company  from  December  1994 to June  1999.  He was in charge of
technical backstopping,  supervising,  coordination,  managing,  monitoring, and
related  responsibilities.  Prior to that, he was the Vice President,  Technical
and a  Director  of BSI  from  1993.  Dr.  Reddy  has  25  years  of  continuous
international service with the Food and Agricultural Organization ("FAO") of the
United Nations,  dealing with development in Asia, Africa,  and the Pacific.  As
the Chief  Technical  Advisor for the FAO,  Dr.  Reddy was  responsible  for the
implementation and execution of well over 100 projects of numerous technological
disciplines.  Dr.  Krish Reddy also has  several  years of  experience  in field
investigations  and  training  of  staff.  Dr.  Reddy  has a  B.V.S.C  from  the
University  of Madras  (India)  and a M.S.  and  Ph.D.  from the  University  of
Missouri.

     PATRICIA  SPREITZER During the period from 2001 through 2003, Ms. Spreitzer
had been  employed as the  assistant  project  controller  for a publicly  owned
international general contractor.  Prior and subsequent to such employment,  she
has been and is  currently  employed as an office  manager  responsible  for all
administrative  functions including accounts receivable and accounts payable and
payroll.

     FAMILY RELATIONSHIPS. There are no family relationships among any directors
and/or executive officers of the Company.

     LEGAL PROCEEDINGS.  During the past five years, no bankruptcy  petition has
been filed by or against any business of which any executive officer,  director,
promoter or  controlling  shareholder  of the  Company was a general  partner or
executive officer either at the time of the bankruptcy or within two years prior
to that time.  In addition,  during the past five years,  no executive  officer,
director,  promoter  or  controlling  shareholder  of the  Company  has been (i)
convicted in a


<PAGE>



criminal   proceeding  or  become  subject  to  a  pending  criminal  proceeding
(excluding  traffic  violations and other minor  offenses),  (ii) subject to any
order, judgment or decree, not subsequently  reversed,  suspended or vacated, of
any court of  competent  jurisdiction,  permanently  or  temporarily  enjoining,
barring,  suspending or otherwise limiting such person's involvement in any type
of  business,  securities  or banking  activities  or (iii)  found by a court of
competent  jurisdiction  (in a civil action),  the SEC or the Commodity  Futures
Trading Commission to have violated a federal or state securities or commodities
law, and such judgment has not been reversed, suspended or vacated.

     AUDIT COMMITTEE  FINANCIAL  EXPERT.  The Company does not currently have an
audit  committee  financial  expert  serving on it audit  committee  because its
minimal level of operations does not create the need for such an expert.

     COMPLIANCE  WITH  SECTION  16(a) OF THE  SECURITIES  EXCHANGE  ACT OF 1934.
Section  16(a) of the  Securities  Exchange  Act of 1934  (the  "Exchange  Act")
requires  that the Company's  directors  and executive  officers and persons who
beneficially  own more than ten percent of the Company's  common stock file with
the SEC  initial  reports  of  beneficial  ownership  and  reports of changes in
beneficial  ownership of their common stock. Such executive officers,  directors
and  significant  shareholders  are required by SEC  regulations  to furnish the
Company  with  copies  of all  Section  16(a)  reports  that they  file.  To the
Company's knowledge, based solely on a review of such reports and any amendments
thereto furnished to the Company during or with respect to the fiscal year ended
October 31,  2003,  during  such fiscal year none of such  persons has failed to
file on a timely basis any required Section 16(a) report.

     CODE OF ETHICS. The Company does not intend to adopt a Code of Ethics until
such time as its operations  have increased from the current  minimal levels and
additional senior management personnel have been retained.


ITEM 10. EXECUTIVE COMPENSATION.

     EXECUTIVE  OFFICERS  AND  DIRECTORS.  None of the  Company's  officers  are
parties to employment  agreements or other  compensation  arrangements  with the
Company, and one of them received, compensation equal to $72,000 during the last
fiscal  year.  The other  officer  and the  directors  did not  receive  nor are
entitled to, any compensation of any kind from the Company for services provided
during the last fiscal year.

     BOARD  COMPENSATION.  Directors of the Company receive no compensation  for
services provided as a director;  they are,  however,  entitled to reimbursement
for their travel  expenses.  The Company  does not pay any amount for  committee
participation or special assignments of the Board of Directors.


ITEM 11.  SECURITY  OWNERSHIP OF CERTAIN  BENEFICIAL  OWNERS AND  MANAGEMENT AND
          RELATED STOCKHOLDER MATTERS.

     CERTAIN  BENEFICIAL  OWNERS.  The following table sets forth the beneficial
ownership  of the  Company's  common stock (the  Company's  only class of voting
stock) as of February 9, 2005


<PAGE>



as to (i) each person or entity who is known by the Company to own  beneficially
more than  five  percent  of the  Company's  common  stock,  (ii) the  Company's
directors and (iii) all directors and executive officers as a group.


                                                    Number of
                                                     Shares
Beneficial Owner                                   Beneficially     Percentage
Owner                                                Owned (1)     of Class(2)
----------------------------------------------    --------------   ------------

Bio Solutions International, Inc. (3)              2,000,000         12.19%
Environmental Services of Mississippi, LLC (4)     5,120,000         31.20%
Krish V. Reddy (5)                                 1,000,000         6.09%
Sterling Sound, LLC (6)                            2,500,000         15.24%
All Directors and executive officers as a group
(two persons) (7)                                  1,050,000         6.40%
----------------------------
(1)  Beneficial ownership is determined in accordance with the rules of the SEC.
     In computing  the number of shares  beneficially  owned by a person and the
     percentage  ownership  of that person,  shares of common  stock  subject to
     options,   warrants  or  similar  rights  held  by  that  person  that  are
     exercisable  on or  before  April 30,  2005 are  deemed  outstanding.  Such
     shares,  however,  are not deemed outstanding for purposes of computing the
     percentage ownership of any other person. To the Company's  knowledge,  the
     persons  named in the table  have sole  voting  and  investment  power with
     respect to all shares of common stock shown as beneficially  owned by them,
     subject to community  property laws where  applicable  and the  information
     contained in the footnotes to this table.
(2)  Based on 16,09,228 shares of common stock outstanding.
(3)  Address is 1161 James Street, Hattiesburg, Mississippi 39401
(4)  Address is PO Box 16133, Hattiesburg, Mississippi 39403
(5)  Address is 4124 W 4th Street, Hattiesburg, Mississippi 39403
(6)  Address is 606 Post Road East, #608, Westport, Connecticut 06880
(7)  Consists of Krish V. Reddy and Patricia Spreitzer.

     CHANGE IN CONTROL.  In March, 2004, upon completion of the BSM transaction,
the Company's  former  directors and officers  resigned and were replaced by the
current officers and directors.

     EQUITY  COMPENSATION  PLANS. In April, 2002, the Company adopted the Single
Source Financial Services Corporation 2002 Omnibus Securities Plan (the "Plan").
Under the Plan, the Company has available for issuance up to 3,000,000 shares of
its common stock. The Plan was


<PAGE>



adopted  to provide  equity  awards to (i)  selected  employees,  directors  and
consultants  of the  Company  in order to provide  an  opportunity  to acquire a
proprietary  interest  in  the  success  of the  Company,  or to  increase  such
interest,  and to encourage those persons to remain in the employ of the Company
and (ii) help attract new employees with outstanding  qualifications.  Under the
Plan,  the Company can make direct  awards in the form of  restricted  shares of
common  stock or grant  options to acquire  those shares  (which may  constitute
incentive stock options or non-statutory stock options). Of the 3,000,000 shares
available for issuance under the Plan, 2,145,000 of those shares have previously
been issued (although the issuance 250,000 of those shares was later cancelled).
There are no outstanding warrants,  warrants or other rights with respect to the
issuance  of any  shares  under the Plan.  Neither  the  Company  nor any of its
subsidiaries  (i) has issued any shares of the  Company  under any other  equity
compensation  plan,  including any individual  compensation  arrangement or (ii)
currently has any shares of the Company  authorized for issuance under any other
equity compensation plan, including any individual compensation arrangement.


ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

     As a result of the  Reorganization and Stock Purchase Agreement between the
Company and BSP, the Company transferred various loans receivable and payable to
SSET.  Effective  October 31, 2004,  with the transfer of the SSET shares to the
former  control  shareholders,  the balance of the  following  transaction  were
transferred to SSET:

     (1) Sid  Rosenblatt  and  Marty  Becker,  the  spouses  of  former  Company
     directors  Arlene  Rosenblatt  and  Pamela  Becker,  respectively,  have an
     interest in MBB and  CardReady,  which are parties to the CardReady  Option
     previously granted to the Company. See "Item 1. Description of Business."

     (2) As of October 31, 2003, for loans  previously made to the Company,  the
     Company  owed  B.A.A.M.S.,  Inc. a total of  $656,791,  which  consisted of
     $573,680 in principal and $83,111in accrued interest.  The amounts advanced
     are  evidenced by promissory  notes and are assessed  interest at an annual
     rate of 8%. The principal balance and accrued interest become fully due and
     payable in a balloon payment on April 1, 2006.

     (3) Over the past  several  years,  Arnold F. Sock,  the  Company's  former
     President and a former  director,  lent money to both the Company and SSET.
     As of October  31,  2003,  the  Company  owed Mr.  Sock a total of $54,929,
     consisting  of $53,249 in  principal  and $1,680 in accrued  interest.  The
     amounts  advanced  are  evidenced  by  promissory  notes  and are  assessed
     interest  at an  annual  rate of 8%.  The  principal  balance  and  accrued
     interest  become  fully due and  payable  in a balloon  payment on April 1,
     2006.  As of October 31,  2003,  the Company  also owed Mr. Sock a total of
     $1,232 for loans to SSET,  consisting of $1,232 in principal and no accrued
     interest.  The amounts  advanced are evidenced by a promissory note and are
     not assessed interest.  The principal balance becomes fully due and payable
     in a balloon payment on April 1, 2006.

     (4) As of October 31, 2003, for loans  previously made to the Company,  the
     Company owed BMS Associates (a partnership  which includes Sid  Rosenblatt,
     Marty  Becker and Brandon  Becker (the  latter  being a former  substantial
     shareholder  of the Company)) a total of $93,038,  consisting of $91,199 in
     principal  and  $1,839  in  accrued  interest.  The  amounts  advanced  are
     evidenced by a


<PAGE>



     promissory  note and are  assessed  interest  at an annual  rate of 8%. The
     principal  balance and accrued  interest  become fully due and payable in a
     balloon payment on April 1, 2006.

     (5) As of October 31, 2003, for loans  previously made to the Company,  the
     Company owed Debt Alliance  Services  Corporation (a  corporation  owned by
     Arnold F. Sock) a total of $36,567,  consisting of $33,670 in principal and
     $2,897 in accrued  interest.  As of October 31, 2003, the Company also owed
     Debt Alliance Services  Corporation a total of $36,567 for loans previously
     made to SSET, which consisted of $33,670 in principal and $2,897 in accrued
     interest.  The amounts  advanced are evidenced by promissory  notes and are
     assessed  interest  at an annual  rate of 8%.  The  principal  balance  and
     accrued interest become fully due and payable in a balloon payment on April
     1, 2006.

     (6) As of October 31, 2003, for loans  previously made to the Company,  the
     Company owed Debt Negotiators, Inc. (a corporation owned by Arnold F. Sock)
     a total of $19,745,  consisting of $19,028 in principal and $717 in accrued
     interest.  As of October 31, 2003, the Company also owed Debt  Negotiators,
     Inc. a total of $19,745 for loans  previously made to SSET, which consisted
     of $19,028 in principal, and $717 in accrued interest. The amounts advanced
     are  evidenced by promissory  notes and are assessed  interest at an annual
     rate of 8%. The principal balance and accrued interest become fully due and
     payable in a balloon payment on April 1, 2006.

     (7) As of October 31, 2003, for loans  previously made to the Company,  the
     Company owed Westside Commercial  Investments,  LLC (an entity owned by Sid
     Rosenblatt and Marty Becker) a total of $25,819, which consisted of $25,053
     in  principal  and $766 in  accrued  interest.  The  amounts  advanced  are
     evidenced by promissory  notes and are assessed  interest at an annual rate
     of 8%. The  principal  balance and accrued  interest  become  fully due and
     payable in a balloon payment on April 1, 2006.

     In connection with the acquisition of all the issued and outstanding shares
of BSP by the Company, Arnold F. Sock, Sid Rosenblatt,  Marty Becker and Brandon
Becker   provided   certain   representations,    warranties,    covenants   and
indemnifications  to BSP.  As part of the  transaction  the  Company's  debts to
Arnold  Sock,   B.A.A.M.S.,   Inc.,  BMS  Associates  and  Westside   Commercial
Investments,  LLC, as  described  above,  were repaid at a discounted  rate.  In
addition,  the  Reorganization and Stock Purchase Agreement provided that if the
SSET  spin-off was not  completed  within six months of the closing,  the former
control  shareholders,  or their designees,  had the option to purchase the SSET
shares owned by the Company for nominal consideration. This option was exercised
in November, 2004.


ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K.

         (a) Exhibits and Exhibit Index.

Exhibit No.                               Description
-----------       --------------------------------------------------------

3.1       Certificate of Incorporation, as amended, of the Company (1)

3.2       Bylaws of the Company (1)

4.1       Single Source Financial  Services  Corporation 2002 Omnibus Securities
          Plan (the "Plan") (2)

4.2       Form of Incentive Stock Option  Agreement  relating to options granted
          under the Plan (2)

<PAGE>




4.3       Form of Non  Statutory  Stock  Option  Agreement  relating  to options
          granted under the Plan (2)

4.4       Form of Common Stock Purchase  Agreement  relating to restricted stock
          granted under the Plan (2)

10.1      Agreement  between  the Company and Sabita  Dhingra  dated  October 3,
          2001(3)

10.2      Agreement  between the Company and Onkar Holdings,  Inc. dated October
          3, 2001(3)

10.3      Agreement between the Company and Ardele (International) dated October
          3, 2001(3)

10.4      Agreement  between the Company and Sabaco  Investment  Advisors  dated
          October 3, 2001(3)

10.5      Restated  Letter of Intent  dated  April 29,  2002 by and  between the
          Company, MBBRAMAR, INC. and CardReady International, Inc. (4)

10.6      Notice of Exercise of Option  dated April 29, 2002 (4)  Reorganization
          and Stock  Purchase  Agreement  between the Company and Bio  Solutions
          Production, Inc. (5)

21        Subsidiaries of the Company

31.1*     Certification  of  Principal   Executive   Officer  pursuant  to  Rule
          13a-14(a) of the Exchange Act

31.2*     Certification  of  Principal   Financial   Officer  pursuant  to  Rule
          13a-14(a) of the Exchange Act

32*       Certification of Principal  Executive Officer and Principal  Financial
          Officer  pursuant to Rule  13a-14(b) of the Exchange Act and 18 U.S.C.
          Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
          Act of 2002

 --------------------
(1)  Incorporated  by reference  from Company's  Registration  Statement on Form
     SB-2 filed with the Commission on November 22, 2000 (File No. 333-50512).
(2)  Incorporated by reference from Company's Registration Statement on Form S-8
     filed with the Commission on April 19, 2002 (File No. 333-86634).
(3)  Incorporated by reference from Company's Registration Statement on Form S-8
     filed with the Commission on October 9, 2001 (File No. 33-71222).
(4)  Incorporated by reference from Company's Report on Form 8-K dated April 29,
     2002 (File No. 0-33229).
(5)  Incorporated by reference from Company's  Report on Form 8-K filed April 2,
     2004 (File No. 0471390).


     (b) Reports on Form 8-K.

     (1) Current Report on Form 8-K, filed  September 1, 2004 pursuant to Item 8
     (Other Events)

     (2) Current Report on form 8-K, filed October 27, 2004 pursuant to Item 5.2
(Resignation of Principal Officer)






<PAGE>



ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

FEE SUMMARY. The following is a summary of the fees billed to the Company by
Baum and Company, LLC, for professional services rendered for the fiscal year
ended October 31, 2003 and to Jonathon Reuben, CPA, An Accountancy Corporation
for the fiscal year ended October 31, 2003:



  Fee Category          Fiscal 2004 Fees            Fiscal 2003 Fees
--------------------    ----------------            ----------------
Audit Fees (1)              $17,500                     $21,245
Audit-related Fees (2)      $0                          $0
Tax Fees (3)                $0                          $0
All Other Fees (4)          $0                          $0

TOTAL FEES                  $17,500                     $21,245
                            =======                     =======

 ----------------
(1)  Consists of fees billed for professional services rendered for the audit of
     the Company's  consolidated  financial statements and review of the interim
     consolidated   financial  statements  included  in  quarterly  reports  and
     services that are normally provided by Baum and Company, LLC for the fiscal
     year ended  October 31, 2004 and by Jonathon  Reuben,  CPA, An  Accountancy
     Corporation  for the fiscal year ended October 31, 2003 in connection  with
     statutory and regulatory filings or engagements.
(2)  There were no audit-related services provided in fiscal 2004 or 2003.
(3)  There were no tax-related services provided in fiscal 2004 or 2003.
(4)  Other than the services reported above,  there were no fees for products or
     services incurred in fiscal 2004 or 2003.

         POLICY ON AUDIT COMMITTEE PRE-APPROVAL OF AUDIT AND PERMISSIBLE
                  NON-AUDIT SERVICES OF INDEPENDENT AUDITORS.

     The policy of the Company's Audit Committee is to pre-approve all audit and
permissible  non-audit  services  provided by the  independent  auditors.  These
services may include audit services,  audit-related  services,  tax services and
other services.  Pre-approval  is generally  provided for up to one year and any
pre-approval  is detailed as to the  particular  service or category of services
and is generally  subject to a specific  budget.  The  independent  auditors and
management are required to periodically  report to the Audit Committee regarding
the extent of services  provided by the independent  auditors in accordance with
this  pre-approval,  and the fees for the services  performed to date. The Audit
Committee may also pre-approve particular services on a case-by-case basis.







                                   SIGNATURES



     In accordance  with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the  undersigned,  thereto duly
authorized.

                        BIO SOLUTIONS MANUFACTURING, INC.


Dated: January 12, 2006       By:  /s/ David S. Bennett
                                ---------------------------------
                                David S. Bennett
                                Chief Executive Officer and Director


         In accordance with the Exchange Act, this report has been signed below
by the following persons on behalf of the registrant and in the capacities and
on the dates indicated.


Dated: January 12, 2006       By:  /s/ Patricia M. Spreitzer
                                ---------------------------------
                              Patricia M. Spreitzer, Secretary,
                              Chief Financial Officer, and Director



Dated: January 12, 2006       By: /s/ Robert Knorr
                              -----------------------------------
                              Robert Knorr, Director

Dated: January 12, 2006       By: /s/ Michael O'Gorman
                              -----------------------------------
                              Michael O'Gorman, Director